Margaret Tisdale

5.0k citations

64 papers · 4.1k indexed · 1 hit paper · h-index 33

Virology top 0.2%
- HIV Research and Treatment 41
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 39
- HIV/AIDS Research and Interventions 17
Epidemiology top 2%
- Influenza Virus Research Studies 14
- Respiratory viral infections research 7
Hepatology top 5%
- Hepatitis C virus research 8
Molecular Biology top 10%
- Biochemical and Molecular Research 5
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4

Co-authors: N. R. Parry Brendan Larder Sharon D. Kemp Richard Myers Barbara Maschera Edward D. Blair G. Darby Diane J. Cousens
Cited by: Virology Infectious Diseases Epidemiology
Journals: Nature (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Margaret Tisdale

63 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Margaret Tisdale

Since Specialization

Citations

This map shows the geographic impact of Margaret Tisdale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Tisdale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Tisdale more than expected).

Fields of papers citing papers by Margaret Tisdale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Tisdale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Tisdale. The network helps show where Margaret Tisdale may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Margaret Tisdale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Margaret Tisdale Line = papers co-authored together Margaret Tisdale links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques Antiviral Research ·Koert J. Stittelaar,Margaret Tisdale,G VANAMERONGEN,R VANLAVIEREN,F.H.M. Pistoor,James H. Simon,Albert D. M. E. Osterhaus	2008	30
2	Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Clinical Therapeutics ·Craig LaForce,Choy Man,Frederick W. Henderson,Janet E. McElhaney,Frank C. Hampel,Robert Bettis,Laila Kudule,Julia Harris,Philip Yates,Margaret Tisdale,Alison Webster	2007	43
3	Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance AIDS ·Lisa Ross,Neil Parkin,Colombe Chappey,Robin Fisher,Marty St. Clair,Michael Bates,Margaret Tisdale,E. Randall Lanier	2004	35
4	Effect of concurrent zidovudine use on the resistance pathway selected by abacavir‐containing regimens HIV Medicine ·ER Lanier,Naomi Givens,Christopher Stone,Philip Griffin,Diana M. Gibb,Sarah Walker,Margaret Tisdale,David M. Irlbeck,Mark Underwood,Marty St. Clair,Mounir Ait‐Khaled	2004	30
5	M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine AIDS ·Mounir Ait‐Khaled,Christopher Stone,Gillian Amphlett,Bonaventura Clotet,Schlomo Staszewski,Christine Katlama,Margaret Tisdale	2002	41
6	Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In Vitro Journal of Virology ·Michael Maguire,Rosario Guinea,Philip Griffin,S. MacManus,Robert C. Elston,Josie Wolfram,Naomi Richards,Mary H. Hanlon,David Porter,Terri Wrin,Neil Parkin,Margaret Tisdale,Eric S. Furfine,C. Petropoulos,B. Wendy Snowden,Jőrg‐Peter Kleim	2002	117
7	Characterization of 2 Influenza A(H3N2) Clinical Isolates with Reduced Susceptibility to Neuraminidase Inhibitors Due to Mutations in the Hemagglutinin Gene The Journal of Infectious Diseases ·Yacine Abed,Anne–Marie Bourgault,Robert J. Fenton,Peter J. Morley,David Gower,Ian J. Owens,Margaret Tisdale,Guy Boivin	2002	49
8	A Phase II Trial of Dual Protease Inhibitor Therapy: Amprenavir in Combination With Indinavir, Nelfinavir, or Saquinavir JAIDS Journal of Acquired Immune Deficiency Syndromes ·Joseph J. Eron,Richard Haubrich,William Lang,Grace Pagano,Judith Millard,Josie Wolfram,Wendy Snowden,Louise Pedneault,Margaret Tisdale	2001	15
9	HIV Type 1 Protease Cleavage Site Mutations and Viral Fitness: Implications for Drug Susceptibility Phenotyping Assays AIDS Research and Human Retroviruses ·Laurence Robinson,Richard Myers,B. Wendy Snowden,Margaret Tisdale,Edward D. Blair	2000	49
10	HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy AIDS ·Veronica Miller,Mounir Ait‐Khaled,Christopher Stone,Philip Griffin,D. Mesogiti,Amy Cutrell,Richard Harrigan,Schlomo Staszewski,Christine Katlama,Gillian Pearce,Margaret Tisdale	2000	107
11	Development of a Sensitive Chemiluminescent Neuraminidase Assay for the Determination of Influenza Virus Susceptibility to Zanamivir Analytical Biochemistry ·Rachel C. Buxton,Brooks S. Edwards,Rouh R. Juo,John C. Voyta,Margaret Tisdale,Richard C. Bethell	2000	108
12	Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors Reviews in Medical Virology ·Margaret Tisdale	2000	121
13	A Novel Genotype Encoding a Single Amino Acid Insertion and Five Other Substitutions Between Residues 64 and 74 of the HIV-1 Reverse Transcriptase Confers High-Level Cross-Resistance to Nucleoside Reverse Transcriptase Inhibitors JAIDS Journal of Acquired Immune Deficiency Syndromes ·Abdelrahim Rakik,Mounir Ait‐Khaled,Philip Griffin,Deborah A. Thomas,Margaret Tisdale,Jőrg‐Peter Kleim	1999	19
14	In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir Virology ·Jacqueline M. Barnett,A. Cadman,Fiona Burrell,Safia Madar,Andrew Lewis,Margaret Tisdale,Richard C. Bethell	1999	63
15	Pharmacodynamics of 141W94 as determined by short term change in HIV RNA Influence of viral isolate baseline EC50 George L. Drusano,Brian M. Sadler,Judith Millard,William T. Symonds,Margaret Tisdale,C. Rawls,Alan Bye	1997	4
16	In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents Antiviral Research ·M H St Clair,Judith Millard,John P. Rooney,Margaret Tisdale,N. R. Parry,Brian M. Sadler,Martin Blum,George R. Painter	1996	65
17	Human Immunodeficiency Virus Journal of Biological Chemistry ·Barbara Maschera,G. Darby,Giorgio Palù,Lois L. Wright,Margaret Tisdale,Richard Myers,Edward D. Blair,Eric S. Furfine	1996	300
18	Purine 2'-deoxy-2'-fluororibosides as antiinfluenza virus agents Journal of Medicinal Chemistry ·Joel V. Tuttle,Margaret Tisdale,Thomas A. Krenitsky	1993	53
19	Monoclonal Antibodies Define Linear and Conformational Epitopes of HIV-1 pol Gene Products AIDS Research and Human Retroviruses ·R. B. Ferns,Jane C. Partridge,Margaret Tisdale,NEIL HUNT,Richard S. Tedder	1991	17
20	Mutations within the RNase H Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Abolish Virus Infectivity Journal of General Virology ·Margaret Tisdale,Tobias Schulze,B. A. Larder,Karin Moelling	1991	129

About Margaret Tisdale

Margaret Tisdale is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 64 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (41 papers), HIV/AIDS drug development and treatment (39 papers), HIV/AIDS Research and Interventions (17 papers), Influenza Virus Research Studies (14 papers), Hepatitis C virus research (8 papers), Respiratory viral infections research (7 papers), Biochemical and Molecular Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Virology (2.4k citations), Infectious Diseases (2.8k citations) and Epidemiology (1.3k citations). Margaret Tisdale has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include N. R. Parry, Brendan Larder, Sharon D. Kemp, Richard Myers, Barbara Maschera, Edward D. Blair, G. Darby, Diane J. Cousens, J. W. T. Selway and Eric S. Furfine. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact